0001127602-22-009483.txt : 20220316 0001127602-22-009483.hdr.sgml : 20220316 20220316163916 ACCESSION NUMBER: 0001127602-22-009483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spurr Robert CENTRAL INDEX KEY: 0001543795 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 22745387 MAIL ADDRESS: STREET 1: C/O BAUSCH HEALTH COMPANIES INC. STREET 2: 400 SOMERSET CORPORATE BLVD. CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-03-15 0000885590 Bausch Health Companies Inc. BHC 0001543795 Spurr Robert C/O BAUSCH HEALTH COMPANIES, INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 1 U.S. President-Pharma Business Common Shares, No Par Value 2022-03-15 4 S 0 4846 22.20 D 92101 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021. /s/ Debra E. Levin, attorney-in-fact for Robert A. Spurr 2022-03-16